Clinical Data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data BioSpaceModerna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.Clinical DataRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) BioSpace Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer. Clinical DataRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: MSD, Eisai report setback in first-line kidney cancer trialNext: Novo Nordisk preps filings for sickle cell drug etavopivat Related Stories Clinical Data Boehringer advances duo for aggressive cancers into phase 3 pharminent June 22, 2026 Clinical Data Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short pharminent June 17, 2026 Clinical Data EHA26: BMS touts positive multiple myeloma data for two pipeline candidates pharminent June 17, 2026
